Loading...
XNAS
BEATW
Market cap34mUSD
Aug 01, Last price  
0.24USD
1D
-12.54%
IPO
-71.52%
Name

Heartbeam Inc

Chart & Performance

D1W1MN
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
26.68%
Rev. gr., 5y
%
Revenues
0k
30,937,72833,922,80172,992,186120,454,000140,621,000119,924,000119,022,000111,494,000129,501,000166,578,000178,513,000208,332,000286,776,000399,472,000000000
Net income
-19m
L+32.85%
-11,463,257-7,644,732-358,0719,205,000-20,476,000-19,860,000-61,422,000-12,202,000-7,319,000-9,793,0007,428,00053,437,000-15,956,00042,820,000-778,000-1,348,000-6,593,000-12,827,000-14,639,000-19,448,000
CFO
-14m
L+19.66%
-2,912,729-237,63910,308,0007,904,00010,362,0005,030,0005,743,00011,259,0008,811,00014,350,00038,851,00023,782,00072,746,000-218,000-600,000-3,230,000-9,948,000-12,093,000-14,471,000

Profile

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
URL
https://www.heartbeam.com/
IPO date
Oct 14, 2021
Employees
10
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
19,887
15,314
13,031
Unusual Expense (Income)
NOPBT
(19,887)
(15,314)
(13,031)
NOPBT Margin
Operating Taxes
(135)
Tax Rate
NOPAT
(19,887)
(15,314)
(12,896)
Net income
(19,448)
32.85%
(14,639)
14.13%
(12,827)
94.55%
Dividends
Dividend yield
Proceeds from repurchase of equity
730
24,764
350
BB yield
-1.19%
-51.83%
-0.88%
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
(2,377)
(16,189)
(3,594)
Cash flow
Cash from operating activities
(14,471)
(12,093)
(9,948)
CAPEX
(201)
(256)
Cash from investing activities
(201)
(256)
Cash from financing activities
866
24,994
350
FCF
(20,081)
(15,570)
(12,678)
Balance
Cash
2,377
16,189
3,594
Long term investments
Excess cash
2,377
16,189
3,594
Stockholders' equity
(56,270)
(36,822)
(22,185)
Invested Capital
57,924
52,759
24,559
ROIC
ROCE
EV
Common stock shares outstanding
26,645
20,333
8,169
Price
2.30
-2.13%
2.35
-51.84%
4.88
58.44%
Market cap
61,284
28.25%
47,783
19.87%
39,862
65.72%
EV
58,907
31,594
36,268
EBITDA
(19,880)
(15,314)
(13,031)
EV/EBITDA
Interest
66
Interest/NOPBT